In a recent study posted to the bioRxiv preprint server, researchers demonstrated the potent neutralizing ability of a polyclonal equine antibody (Ab), FBR-002, against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs), including Omicron.
A new study presents a comprehensive analysis of the potential of both Omicron BA.2 and BA.3 to become the next dominant circulating SARS-CoV-2 strain.
A new study aimed to determine the timelessness of SARS-CoV-2 seroprevalence studies in providing information that is useful in public health surveillance.
In this interview, News-Medical talks to Professor Adam Rose and his research team about how direct behavioral responses to COVID-19 have impacted the US economy.